Treatment with an inhibitory anti-IL-6 antibody inhibited growth of LCLs in SCID mice, and remission was observed in 8/12 patients with post-transplant lymphoproliferative disorder upon treatment with the anti-IL-6 antibody [104]. This evidence concerns the gene IL6 and lymphoproliferative syndrome.